These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 15290916)

  • 1. Serum procalcitonin differentiates inflammatory bowel disease and self-limited colitis.
    Herrlinger KR; Dittmann R; Weitz G; Wehkamp J; Ludwig D; Schwab M; Stange EF; Fellermann K
    Inflamm Bowel Dis; 2004 May; 10(3):229-33. PubMed ID: 15290916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of serum procalcitonin in determining the activity of inflammatory bowel disease.
    Oruç N; Ozütemiz O; Osmanoğlu N; Ilter T
    Turk J Gastroenterol; 2009 Mar; 20(1):9-12. PubMed ID: 19330729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of serum procalcitonin in patients with ulcerative colitis.
    Koido S; Ohkusa T; Takakura K; Odahara S; Tsukinaga S; Yukawa T; Mitobe J; Kajihara M; Uchiyama K; Arakawa H; Tajiri H
    World J Gastroenterol; 2013 Dec; 19(45):8335-41. PubMed ID: 24363525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additional benefit of procalcitonin to C-reactive protein to assess disease activity and severity in Crohn's disease.
    Oussalah A; Laurent V; Bruot O; Guéant JL; Régent D; Bigard MA; Peyrin-Biroulet L
    Aliment Pharmacol Ther; 2010 Nov; 32(9):1135-44. PubMed ID: 21039675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of procalcitonin in infectious gastroenteritis and inflammatory bowel disease.
    Thia KT; Chan ES; Ling KL; Ng WY; Jacob E; Ooi CJ
    Dig Dis Sci; 2008 Nov; 53(11):2960-8. PubMed ID: 18415679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum procalcitonin and C-reactive protein in children with diarrhoea of various aetiologies.
    Korczowski B; Szybist W
    Acta Paediatr; 2004 Feb; 93(2):169-73. PubMed ID: 15046268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procalcitonin in Crohn's disease with fever episodes, a variable to differentiate intra-abdominal abscess from disease flares.
    Ge X; Hu D; Cao Y; Liu Z; Ding C; Tian H; Gong J; Zhu W; Li N; Li J
    Int J Surg; 2016 Dec; 36(Pt A):34-39. PubMed ID: 27743896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential diagnosis of bacterial infection and inflammatory response in kidney diseases using procalcitonin.
    Sitter T; Schmidt M; Schneider S; Schiffl H
    J Nephrol; 2002; 15(3):297-301. PubMed ID: 12113602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes?
    Delèvaux I; André M; Colombier M; Albuisson E; Meylheuc F; Bègue RJ; Piette JC; Aumaître O
    Ann Rheum Dis; 2003 Apr; 62(4):337-40. PubMed ID: 12634233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease.
    Karmiris K; Koutroubakis IE; Xidakis C; Polychronaki M; Voudouri T; Kouroumalis EA
    Inflamm Bowel Dis; 2006 Feb; 12(2):100-5. PubMed ID: 16432373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum procalcitonin and C-reactive protein for differentiating bacterial infection from disease activity in patients with systemic lupus erythematosus.
    Yu J; Xu B; Huang Y; Zhao J; Wang S; Wang H; Yang N
    Mod Rheumatol; 2014 May; 24(3):457-63. PubMed ID: 24252006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs. viral infections.
    Gendrel D; Raymond J; Coste J; Moulin F; Lorrot M; Guérin S; Ravilly S; Lefèvre H; Royer C; Lacombe C; Palmer P; Bohuon C
    Pediatr Infect Dis J; 1999 Oct; 18(10):875-81. PubMed ID: 10530583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity.
    Brandhorst G; Weigand S; Eberle C; Raddatz D; Karaus M; Oellerich M; Walson PD
    Clin Chim Acta; 2013 Jun; 421():31-3. PubMed ID: 23485644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procalcitonin in inflammatory bowel disease: Drawbacks and opportunities.
    Lippi G; Sanchis-Gomar F
    World J Gastroenterol; 2017 Dec; 23(47):8283-8290. PubMed ID: 29307988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of procalcitonin, C-reactive protein, interleukin-6 & serum amyloid A as diagnostic biomarkers of bacterial infection in febrile patients.
    Qu J; L X; Liu Y; Wang X
    Indian J Med Res; 2015 Mar; 141(3):315-21. PubMed ID: 25963492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
    Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B
    World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procalcitonin is a specific marker for detecting bacterial infection in patients with rheumatoid arthritis.
    Sato H; Tanabe N; Murasawa A; Otaki Y; Sakai T; Sugaya T; Ito S; Otani H; Abe A; Ishikawa H; Nakazono K; Kuroda T; Nakano M; Narita I
    J Rheumatol; 2012 Aug; 39(8):1517-23. PubMed ID: 22753652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early detection of an early onset infection in the neonate based on measurements of procalcitonin and C-reactive protein concentrations in cord blood.
    Kordek A; Hałasa M; Podraza W
    Clin Chem Lab Med; 2008; 46(8):1143-8. PubMed ID: 18590465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of procalcitonin determinations in evaluation of systemic lupus erythematosus.
    Quintana G; Medina YF; Rojas C; Fernandez A; Restrepo JF; Rondon F; Iglesias A
    J Clin Rheumatol; 2008 Jun; 14(3):138-42. PubMed ID: 18525431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pro-calcitonin and inflammation in chronic hemodialysis.
    Trimarchi H; Dicugno M; Muryan A; Lombi F; Iturbe L; Raña MS; Young P; Nau K; Iriarte R; Pomeranz V; Forrester M; Karl A; Alonso M
    Medicina (B Aires); 2013; 73(5):411-6. PubMed ID: 24152395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.